Parekar Reshma R, Bolegave Somesh S, Marathe Padmaja A, Rege Nirmala N
Department of Medical Services, Ranbaxy Laboratories Ltd., Borivali East, Mumbai, India.
Department of Pharmacology and Therapeutics, Seth GSMC and KEM Hospital, Parel, Mumbai, India.
J Ayurveda Integr Med. 2015 Jan-Mar;6(1):11-8. doi: 10.4103/0975-9476.146565.
Dashamoola, in the form of arishta and kwath, is a commonly used classical Ayurvedic multi-ingredient formulation for management of pain, arthritis and inflammatory disorders.
To study analgesic, anti-inflammatory and anti-platelet activity of Dashamoola and its combination with aspirin.
Wistar albino rats (180-200 g) and Swiss albino mice (20-25 g) of either sex were divided randomly into five groups: Distilled water, aspirin (500mg/kg in rats; 722.2 mg/kg in mice), Dashamoolarishta (1.8 mL/kg in rats; 2.5 mL/kg in mice) and Dashamoolarishta with aspirin. Anti-inflammatory activity was measured by change in paw volume in carrageenan-induced inflammation, protein content in model of peritonitis and granuloma weight in cotton pellet granuloma. Analgesic effect was evaluated by counting number of writhes in writhing model. Maximum platelet aggregation and percentage inhibition of ADP and collagen-induced platelet aggregation were estimated in vitro. Statistical analysis was done using one way ANOVA (post hoc Tukey's test) and P < 0.05 was considered significant.
Dashamoolarishta and its combination with aspirin showed significantly (P < 0.01) less number of writhes. It showed significant (P < 0.001) anti-inflammatory activity by paw edema reduction in rats, decrease in proteins in peritoneal fluid (P < 0.001) and decrease in granuloma weight (P < 0.05) as compared to respective vehicle control groups. Dashamoola kwath alone and in combination with aspirin inhibited maximum platelet aggregation and percent inhibition of platelets as compared to vehicle (P < 0.001).
Dashamoola formulation alone and its combination with aspirin showed comparable anti-inflammatory, analgesic and anti-platelet effects to aspirin.
达沙穆拉(Dashamoola)制成阿黎什塔(arishta)和夸特(kwath)的剂型,是一种常用于治疗疼痛、关节炎和炎症性疾病的经典阿育吠陀多成分制剂。
研究达沙穆拉及其与阿司匹林联用的镇痛、抗炎和抗血小板活性。
将体重180 - 200克的Wistar白化大鼠和体重20 - 25克的瑞士白化小鼠随机分为五组:蒸馏水组、阿司匹林组(大鼠500毫克/千克;小鼠722.2毫克/千克)、达沙穆拉阿黎什塔组(大鼠1.8毫升/千克;小鼠2.5毫升/千克)以及达沙穆拉阿黎什塔与阿司匹林联用组。通过角叉菜胶诱导炎症模型中爪体积的变化、腹膜炎模型中的蛋白质含量以及棉球肉芽肿模型中的肉芽肿重量来测定抗炎活性。通过扭体模型中扭体次数来评估镇痛效果。在体外估计最大血小板聚集以及二磷酸腺苷(ADP)和胶原诱导的血小板聚集的抑制百分比。采用单因素方差分析(事后Tukey检验)进行统计分析,P < 0.05被认为具有显著性。
与各自的溶媒对照组相比,达沙穆拉阿黎什塔及其与阿司匹林联用组的扭体次数显著减少(P < 0.01)。通过减轻大鼠爪部水肿、降低腹腔液中的蛋白质含量(P < 0.001)以及减轻肉芽肿重量(P < 0.05),显示出显著的(P < 0.001)抗炎活性。与溶媒组相比,单独的达沙穆拉夸特及其与阿司匹林联用组抑制了最大血小板聚集以及血小板抑制百分比(P < 0.001)。
单独的达沙穆拉制剂及其与阿司匹林联用显示出与阿司匹林相当的抗炎、镇痛和抗血小板作用。